The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Myasthenia Gravis Market Research Report 2025

Global Myasthenia Gravis Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1979037

No of Pages : 82

Synopsis
Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (the muscles that connect to your bones and contract to allow body movement in the arms and legs, and allow for breathing).
The global Myasthenia Gravis market was valued at US$ 1185 million in 2023 and is anticipated to reach US$ 1955.9 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Myasthenia Gravis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Myasthenia Gravis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Myasthenia Gravis in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Myasthenia Gravis include Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca and Avadel Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Myasthenia Gravis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myasthenia Gravis.
Report Scope
The Myasthenia Gravis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Myasthenia Gravis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myasthenia Gravis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Roche
CSL Limited
Baxter International
Novartis
Bausch Health
Grifols
AstraZeneca
Avadel Pharmaceuticals
Octapharma
Astellas Pharma
Zydus Lifesciences
Kedrion S.p.A.
Segment by Type
Monoclonal Antibodies
Intravenous Immunoglobulin
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Intravenous Immunoglobulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Market Perspective (2019-2030)
2.2 Myasthenia Gravis Growth Trends by Region
2.2.1 Global Myasthenia Gravis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Myasthenia Gravis Historic Market Size by Region (2019-2024)
2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2025-2030)
2.3 Myasthenia Gravis Market Dynamics
2.3.1 Myasthenia Gravis Industry Trends
2.3.2 Myasthenia Gravis Market Drivers
2.3.3 Myasthenia Gravis Market Challenges
2.3.4 Myasthenia Gravis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Players by Revenue
3.1.1 Global Top Myasthenia Gravis Players by Revenue (2019-2024)
3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2019-2024)
3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Myasthenia Gravis Revenue
3.4 Global Myasthenia Gravis Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2023
3.5 Myasthenia Gravis Key Players Head office and Area Served
3.6 Key Players Myasthenia Gravis Product Solution and Service
3.7 Date of Enter into Myasthenia Gravis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Breakdown Data by Type
4.1 Global Myasthenia Gravis Historic Market Size by Type (2019-2024)
4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2025-2030)
5 Myasthenia Gravis Breakdown Data by Application
5.1 Global Myasthenia Gravis Historic Market Size by Application (2019-2024)
5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Myasthenia Gravis Market Size (2019-2030)
6.2 North America Myasthenia Gravis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Myasthenia Gravis Market Size by Country (2019-2024)
6.4 North America Myasthenia Gravis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myasthenia Gravis Market Size (2019-2030)
7.2 Europe Myasthenia Gravis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Myasthenia Gravis Market Size by Country (2019-2024)
7.4 Europe Myasthenia Gravis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Market Size (2019-2030)
8.2 Asia-Pacific Myasthenia Gravis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Myasthenia Gravis Market Size by Region (2019-2024)
8.4 Asia-Pacific Myasthenia Gravis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis Market Size (2019-2030)
9.2 Latin America Myasthenia Gravis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Myasthenia Gravis Market Size by Country (2019-2024)
9.4 Latin America Myasthenia Gravis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Market Size (2019-2030)
10.2 Middle East & Africa Myasthenia Gravis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Myasthenia Gravis Market Size by Country (2019-2024)
10.4 Middle East & Africa Myasthenia Gravis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Myasthenia Gravis Introduction
11.1.4 Takeda Revenue in Myasthenia Gravis Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Myasthenia Gravis Introduction
11.2.4 Roche Revenue in Myasthenia Gravis Business (2019-2024)
11.2.5 Roche Recent Development
11.3 CSL Limited
11.3.1 CSL Limited Company Detail
11.3.2 CSL Limited Business Overview
11.3.3 CSL Limited Myasthenia Gravis Introduction
11.3.4 CSL Limited Revenue in Myasthenia Gravis Business (2019-2024)
11.3.5 CSL Limited Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Detail
11.4.2 Baxter International Business Overview
11.4.3 Baxter International Myasthenia Gravis Introduction
11.4.4 Baxter International Revenue in Myasthenia Gravis Business (2019-2024)
11.4.5 Baxter International Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Myasthenia Gravis Introduction
11.5.4 Novartis Revenue in Myasthenia Gravis Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Detail
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Myasthenia Gravis Introduction
11.6.4 Bausch Health Revenue in Myasthenia Gravis Business (2019-2024)
11.6.5 Bausch Health Recent Development
11.7 Grifols
11.7.1 Grifols Company Detail
11.7.2 Grifols Business Overview
11.7.3 Grifols Myasthenia Gravis Introduction
11.7.4 Grifols Revenue in Myasthenia Gravis Business (2019-2024)
11.7.5 Grifols Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Myasthenia Gravis Introduction
11.8.4 AstraZeneca Revenue in Myasthenia Gravis Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Avadel Pharmaceuticals
11.9.1 Avadel Pharmaceuticals Company Detail
11.9.2 Avadel Pharmaceuticals Business Overview
11.9.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction
11.9.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2019-2024)
11.9.5 Avadel Pharmaceuticals Recent Development
11.10 Octapharma
11.10.1 Octapharma Company Detail
11.10.2 Octapharma Business Overview
11.10.3 Octapharma Myasthenia Gravis Introduction
11.10.4 Octapharma Revenue in Myasthenia Gravis Business (2019-2024)
11.10.5 Octapharma Recent Development
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Detail
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma Myasthenia Gravis Introduction
11.11.4 Astellas Pharma Revenue in Myasthenia Gravis Business (2019-2024)
11.11.5 Astellas Pharma Recent Development
11.12 Zydus Lifesciences
11.12.1 Zydus Lifesciences Company Detail
11.12.2 Zydus Lifesciences Business Overview
11.12.3 Zydus Lifesciences Myasthenia Gravis Introduction
11.12.4 Zydus Lifesciences Revenue in Myasthenia Gravis Business (2019-2024)
11.12.5 Zydus Lifesciences Recent Development
11.13 Kedrion S.p.A.
11.13.1 Kedrion S.p.A. Company Detail
11.13.2 Kedrion S.p.A. Business Overview
11.13.3 Kedrion S.p.A. Myasthenia Gravis Introduction
11.13.4 Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2019-2024)
11.13.5 Kedrion S.p.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Intravenous Immunoglobulin
Table 4. Key Players of Others
Table 5. Global Myasthenia Gravis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Myasthenia Gravis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Myasthenia Gravis Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Myasthenia Gravis Market Share by Region (2019-2024)
Table 9. Global Myasthenia Gravis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Myasthenia Gravis Market Share by Region (2025-2030)
Table 11. Myasthenia Gravis Market Trends
Table 12. Myasthenia Gravis Market Drivers
Table 13. Myasthenia Gravis Market Challenges
Table 14. Myasthenia Gravis Market Restraints
Table 15. Global Myasthenia Gravis Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Myasthenia Gravis Market Share by Players (2019-2024)
Table 17. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2023)
Table 18. Ranking of Global Top Myasthenia Gravis Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Myasthenia Gravis Product Solution and Service
Table 22. Date of Enter into Myasthenia Gravis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Myasthenia Gravis Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Myasthenia Gravis Revenue Market Share by Type (2019-2024)
Table 26. Global Myasthenia Gravis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Myasthenia Gravis Revenue Market Share by Type (2025-2030)
Table 28. Global Myasthenia Gravis Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Myasthenia Gravis Revenue Market Share by Application (2019-2024)
Table 30. Global Myasthenia Gravis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Myasthenia Gravis Revenue Market Share by Application (2025-2030)
Table 32. North America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Myasthenia Gravis Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Myasthenia Gravis Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Myasthenia Gravis Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Myasthenia Gravis Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Myasthenia Gravis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Myasthenia Gravis Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Myasthenia Gravis Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Myasthenia Gravis Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Myasthenia Gravis Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Myasthenia Gravis Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Myasthenia Gravis Market Size by Country (2025-2030) & (US$ Million)
Table 47. Takeda Company Detail
Table 48. Takeda Business Overview
Table 49. Takeda Myasthenia Gravis Product
Table 50. Takeda Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 51. Takeda Recent Development
Table 52. Roche Company Detail
Table 53. Roche Business Overview
Table 54. Roche Myasthenia Gravis Product
Table 55. Roche Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 56. Roche Recent Development
Table 57. CSL Limited Company Detail
Table 58. CSL Limited Business Overview
Table 59. CSL Limited Myasthenia Gravis Product
Table 60. CSL Limited Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 61. CSL Limited Recent Development
Table 62. Baxter International Company Detail
Table 63. Baxter International Business Overview
Table 64. Baxter International Myasthenia Gravis Product
Table 65. Baxter International Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 66. Baxter International Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Myasthenia Gravis Product
Table 70. Novartis Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Bausch Health Company Detail
Table 73. Bausch Health Business Overview
Table 74. Bausch Health Myasthenia Gravis Product
Table 75. Bausch Health Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 76. Bausch Health Recent Development
Table 77. Grifols Company Detail
Table 78. Grifols Business Overview
Table 79. Grifols Myasthenia Gravis Product
Table 80. Grifols Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 81. Grifols Recent Development
Table 82. AstraZeneca Company Detail
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Myasthenia Gravis Product
Table 85. AstraZeneca Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Avadel Pharmaceuticals Company Detail
Table 88. Avadel Pharmaceuticals Business Overview
Table 89. Avadel Pharmaceuticals Myasthenia Gravis Product
Table 90. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 91. Avadel Pharmaceuticals Recent Development
Table 92. Octapharma Company Detail
Table 93. Octapharma Business Overview
Table 94. Octapharma Myasthenia Gravis Product
Table 95. Octapharma Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 96. Octapharma Recent Development
Table 97. Astellas Pharma Company Detail
Table 98. Astellas Pharma Business Overview
Table 99. Astellas Pharma Myasthenia Gravis Product
Table 100. Astellas Pharma Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 101. Astellas Pharma Recent Development
Table 102. Zydus Lifesciences Company Detail
Table 103. Zydus Lifesciences Business Overview
Table 104. Zydus Lifesciences Myasthenia Gravis Product
Table 105. Zydus Lifesciences Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 106. Zydus Lifesciences Recent Development
Table 107. Kedrion S.p.A. Company Detail
Table 108. Kedrion S.p.A. Business Overview
Table 109. Kedrion S.p.A. Myasthenia Gravis Product
Table 110. Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2019-2024) & (US$ Million)
Table 111. Kedrion S.p.A. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myasthenia Gravis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Myasthenia Gravis Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Intravenous Immunoglobulin Features
Figure 5. Others Features
Figure 6. Global Myasthenia Gravis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Myasthenia Gravis Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Myasthenia Gravis Report Years Considered
Figure 12. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Myasthenia Gravis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Myasthenia Gravis Market Share by Region: 2023 VS 2030
Figure 15. Global Myasthenia Gravis Market Share by Players in 2023
Figure 16. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2023
Figure 18. North America Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Myasthenia Gravis Market Share by Country (2019-2030)
Figure 20. United States Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Myasthenia Gravis Market Share by Country (2019-2030)
Figure 24. Germany Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Myasthenia Gravis Market Share by Region (2019-2030)
Figure 32. China Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Myasthenia Gravis Market Share by Country (2019-2030)
Figure 40. Mexico Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Myasthenia Gravis Market Share by Country (2019-2030)
Figure 44. Turkey Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 47. Roche Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 48. CSL Limited Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 49. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 51. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 52. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 54. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 55. Octapharma Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 56. Astellas Pharma Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 57. Zydus Lifesciences Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 58. Kedrion S.p.A. Revenue Growth Rate in Myasthenia Gravis Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’